Table 3.
Number of participants with bacterial vaginosis (BV) status after consuming of food supplements as determined by the Nugent scores in the MED-01 and placebo groups.
| Variable | MED-01 (n = 39) | Placebo (n = 37) | |||
|---|---|---|---|---|---|
| Baseline | 12 Weeks | Baseline | 12 Weeks | p-Value | |
| Nugent score | |||||
| 0–3 (Normal) | - | 10 (25.6%) | - | 5 (13.5%) | 0.382 |
| 4–6 (Intermediate) | 39 (100%) | 23 (59.0%) | 37 (100%) | 24 (64.9%) | |
| 7–9 (BV) | - | 6 (15.4%) | - | 8 (21.6%) | |
Results are expressed as absolute numbers and percentages, respectively. For proportions, a chi-square two-tailed test was used.